West Pharmaceutical Services price to free cash flow WST

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 63.2×
10-year median: 60.8×
Against its 10-year history: 57th; percentile: 0 is its lowest day, 100 its highest
10-year range: 36.2× to 137×
Peer median: 19.8×

West Pharmaceutical Services' price to free cash flow is 63.2× as of Oct 23, 2026.

That is above its ten-year median of 60.8×, close to the middle of its last ten years.

Over that time it ranged from 36.2× in Mar 2026 to 137× in Apr 2017.

The median for 10 medical instruments and supplies stocks of a similar size is 19.8×.

Price to free cash flow over time

median 60.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	63.2×	36.2×	63.2×
2025	52.1×	48.1×	77.7×
2024	75.0×	57.8×	75.0×
2023	62.0×	44.4×	75.9×
2022	44.9×	41.2×	93.7×
2021	103×	65.2×	121×
2020	75.9×	40.1×	79.3×
2019	51.9×	37.8×	55.0×
2018	37.0×	36.6×	71.9×
2017	69.9×	69.1×	137×
2016	129×	51.5×	129×
2015	56.7×	42.7×	71.3×
2014	46.7×	32.1×	51.2×
2013	45.3×	34.8×	82.7×
2012	66.9×	24.2×	89.2×
2011	24.2×	18.3×	25.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest West Pharmaceutical Services' size, closest first, today.

Company	Price to free cash flow
WSTWest Pharmaceutical Services	63.2×
RMDResMed	22.1×
MDLNMedline	n/m
SOLVSolventum	n/m
BDXBecton, Dickinson and	19.8×
PENPenumbra	59.2×
COOCooper Companies	17.2×
ALGNAlign Technology	17.3×
GMEDGlobus Medical	14.5×
PODDInsulet	35.2×
MSAMSA Safety	19.8×
Peer median	19.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on West Pharmaceutical Services

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.